Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06065449 · ClinicalTrials.gov registry record · Phase 3
A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs Conventional Palliative Radiation Therapy for Painful Bone Metastases
A Phase 3 study of Bone Metastases, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 220
- Enrollment target
- 1
- Study location
NCT06065449 is a Phase 3 study of Bone Metastases that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 220 participants, above the 132-participant average among 10 other Bone Metastases trials with a reported enrollment target (67% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06065449, a Phase 3 study of Bone Metastases, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 220 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare increasing doses and different treatment schedules of stereotactic body radiation therapy (SBRT) against standard treatment scheduling.
Conditions Studied
Interventions
- DRUG Radiation Therapy
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2024-01-24 |
| Est. Completion | 2027-06-27 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06065449
The ClinicalTrials.gov registry entry for NCT06065449 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 132-participant average among 10 other Bone Metastases trials with a reported enrollment target (67% higher). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bone Metastases appearing as the primary indexed condition, and to 1 intervention - of which Radiation Therapy is the first listed.
NCT06065449 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06065449 about?
NCT06065449 is a clinical study titled "A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs Conventional Palliative Radiation Therapy for Painful Bone Metastases". To compare increasing doses and different treatment schedules of stereotactic body radiation therapy (SBRT) against standard treatment scheduling.
What is the current status of trial NCT06065449?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 220 participants. The study started on 2024-01-24. Estimated completion is 2027-06-27.
What conditions does trial NCT06065449 study?
This clinical trial studies the following conditions: Bone Metastases.
What interventions are being tested in trial NCT06065449?
The interventions under investigation include: Radiation Therapy (DRUG).
Who is sponsoring clinical trial NCT06065449?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06065449 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bone Metastases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
RECRUITING · Phase 3
-
Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method?
RECRUITING
-
Registry for Bone Metastases
RECRUITING
-
Simulation-Free, Single-Fraction Palliative Radiation Therapy for Treatment of Bone Metastases
RECRUITING · NA
-
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
ACTIVE NOT RECRUITING · NA
-
FDG PET/CT in Breast Cancer Bone Mets
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.